Endocrine oncology

A Data-Driven Approach to Refine Predictions of Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study

J Clin Endocrinol MetabPublished Prospective cohort study

Main findingResult — go to the resultNPV for low-risk patients, increase 3%

Authors' conclusion

Current risk stratification systems may be complemented by the inclusion of other variables in order to improve the prediction of treatment response. A complete dataset allows for more precise patient clustering.

Study context

Population
Consecutive patients with differentiated thyroid cancer (DTC) and at least early follow-up data, Italian Thyroid Cancer Observatory (ITCO) database, 40 Italian centres; median follow-up 26 months (IQR 12–46)
Participants
4,773 patients
Exposure
Data-driven decision tree model vs 2015 American Thyroid Association (ATA) risk stratification
Outcome
Prediction of persistent/recurrent disease
Methodological detailsmulticentre, decision tree model
  • Multicentre
  • Decision tree model

Main finding

As reported in the abstract

NPV for low-risk patients, increase

3%

By group

Decision tree

49%

Sensitivity of high-risk classification for structural disease

ATA

37%

Sensitivity of high-risk classification for structural disease

Observational data: associations, not effects.

Further findings

ATA risk categories

Low risk
2492 (52.2%)
Intermediate risk
1873 (39.2%)
High risk
408

Feature importance

Variables not in the ATA system that significantly impacted prediction of persistence/recurrence: age, BMI, tumor size, sex, family history of thyroid cancer, surgical approach, presurgical cytology, circumstances of diagnosis

Original publication

A Data-Driven Approach to Refine Predictions of Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study. J Clin Endocrinol Metab. Published 16 February 2023. doi:10.1210/clinem/dgad075

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.